Daily Summary of Health · Final editionWednesday 28 October 2026 · UTC
Health News: 28 October 2026
Climate health harms speed up, Ebola vaccine trial starts, FDA eases gene therapy path
The 10th Lancet Countdown report, released Wednesday, found that the health harms of climate change have grown faster in the decade since the Paris Agreement. The first participant has been vaccinated in a trial against the Bundibugyo Ebola strain behind the Congo outbreak, which now exceeds 10,000 cases.
US regulators set out a faster approval route for personalized gene therapies, and a new investigation documents pediatric intensive care units closing across the country.
FDA draft guidance would let one licence cover patient-specific gene therapy variants
The FDA issued draft guidance, released late Tuesday and detailed in coverage on Wednesday, that sets pre-defined limits on how a gene therapy may vary from one patient to the next while staying under a single biologics license application. Under these limits, called an Individualized Feature Space, a new patient-specific variant could be added without more clinical trials if tests show adequate safety and activity.
The Centers for Medicare and Medicaid Services also announced plans to expand its Cell and Gene Therapy Access Model to widen patient access to these costly treatments.
Pediatric intensive care units are closing across the US, forcing sick children to travel farther
In the past year, hospitals in Montana, Oregon and Missouri have closed pediatric intensive care units, including at Community Medical Center in Missoula this month. Hospitals point to low patient numbers, a shortage of pediatric subspecialists and lower payments for treating children. One analysis found the number of hospitals with pediatric inpatient units fell by nearly 30 percent between 2008 and 2022, from 1,749 to 1,226.
Researchers warn that federal Medicaid cuts will widen these gaps, since about half of US children are covered by Medicaid or CHIP.
First volunteer vaccinated in trial against the Ebola strain behind the Congo outbreak
Médecins Sans Frontières says the first participant has been vaccinated in the Tumaini trial. The trial is testing several vaccine candidates against Bundibugyo ebolavirus, a strain with no approved vaccine or treatment, and the first candidate is ERVEBO, a vaccine licensed for the Zaire strain.
It enrolls recent contacts of confirmed cases and is co-led by Congo's national biomedical research institute and the University of Antwerp, with partners including WHO, CEPI and Africa CDC. WHO's Africa office puts the outbreak at more than 10,000 cases and nearly 5,000 deaths, and WHO says imported cases have now been reported in Kenya and Nigeria.
Lancet Countdown: climate-driven health threats are growing faster than a decade ago
The 10th annual Lancet Countdown report, released on Wednesday by an international group of scientists tracking how global warming affects human health, compares the decade since the Paris climate agreement with the decade before it. It found that several major health threats, including deadly heat and drought, rose more quickly after the accord.
This happened even as countries put more money into clean energy and into protecting people from climate hazards.
Illustration 
